TP53 and acute lymphoblastic leukemia: Moreover, TP53 was altered in 12.4% and 6.4% of first-relapse childhood ALL patients with B-cell precursor ALL and T-cell ALL, respectively, with approximately half of the TP53 alterations gained at relapse [345].